Cargando…

Treatment with pCramoll Alone and in Combination with Fluconazole Provides Therapeutic Benefits in C. gattii Infected Mice

Cryptococcus gattii is one of the main causative agents of cryptococcosis in immunocompetent individuals. Treatment of the infection is based on the use of antimycotics, however, the toxicity of these drugs and the increase of drug-resistant strains have driven the search for more effective and less...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jandú, Jannyson J., Costa, Marliete C., Santos, Julliana R. A., Andrade, Fernanda M., Magalhães, Thais F., Silva, Márcia V., Castro, Maria C. A. B., Coelho, Luanna C. B. B., Gomes, Aline G., Paixão, Tatiane A., Santos, Daniel A., Correia, Maria T. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442327/ https://www.ncbi.nlm.nih.gov/pubmed/28596945 http://dx.doi.org/10.3389/fcimb.2017.00211

Ejemplares similares

pCramoll and rCramoll as New Preventive Agents against the Oxidative Dysfunction Induced by Hydrogen Peroxide
por: Nascimento da Silva, Luís Cláudio, et al.
Publicado: (2015)

Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis
por: Santos, Julliana Ribeiro Alves, et al.
Publicado: (2014)

Radiolabeling of Cramoll 1,4: Evaluation of the Biodistribution
por: Ferreira de Carvalho Patricio, Beatriz, et al.
Publicado: (2011)

Topical Application Effect of the Isolectin Hydrogel (Cramoll 1,4) on Second-Degree Burns: Experimental Model
por: dos Santos Tavares Pereira, Danielle, et al.
Publicado: (2012)

Pseudomonas aeruginosa Infection Modulates the Immune Response and Increases Mice Resistance to Cryptococcus gattii
por: Peres-Emidio, Eluzia C., et al.
Publicado: (2022)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Targeting the Immune System with Plant Lectins to Combat Microbial Infections
por: Jandú, Jannyson J. B., et al.
Publicado: (2017)

Commiphora leptophloeos Phytochemical and Antimicrobial Characterization
por: de Souza Pereira, Jorge J., et al.
Publicado: (2017)

Time-Course Proteome Analysis Reveals the Dynamic Response of Cryptococcus gattii Cells to Fluconazole
por: Chong, Hin Siong, et al.
Publicado: (2012)

High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
por: Santos, Julliana Ribeiro Alves, et al.
Publicado: (2017)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
por: Melendres, Javier, et al.
Publicado: (2022)

Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005–2013
por: Naicker, Serisha D., et al.
Publicado: (2022)

Effects of zinc transporters on Cryptococcus gattii virulence
por: Schneider, Rafael de Oliveira, et al.
Publicado: (2015)

Anticandidal Activity of Omiganan and Its Retro Analog Alone and in Combination with Fluconazole
por: Czechowicz, Paulina, et al.
Publicado: (2021)

Modulation of Zinc Homeostasis in Acanthamoeba castellanii as a Possible Antifungal Strategy against Cryptococcus gattii
por: Ribeiro, Nicole S., et al.
Publicado: (2017)

Cryptococcus gattii endogenous chorioretinitis
por: Willett, Keirnan L., et al.
Publicado: (2022)

A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models
por: Sá, Nívea P, et al.
Publicado: (2018)

Genome Variation in Cryptococcus gattii, an Emerging Pathogen of Immunocompetent Hosts
por: D’Souza, C. A., et al.
Publicado: (2011)

Donor-Derived Transmission of Cryptococcus gattii sensu lato in Kidney Transplant Recipients
por: Santos, Daniel W.C.L., et al.
Publicado: (2020)

Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals
por: Helal, Sara H., et al.
Publicado: (2022)

Maternal–Fetal Transmission of Cryptococcus gattii in Harbor Porpoise
por: Norman, Stephanie A., et al.
Publicado: (2011)

Antifungal Activity of Naphthoquinoidal Compounds In Vitro against Fluconazole-Resistant Strains of Different Candida Species: A Special Emphasis on Mechanisms of Action on Candida tropicalis
por: Neto, João B. A., et al.
Publicado: (2014)

Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates
por: Kubiça, Thaís Felli, et al.
Publicado: (2016)

A Randomized, Double-blind Study of Amorolfine 5% Nail Lacquer with Oral Fluconazole Compared with Oral Fluconazole Alone in the Treatment of Fingernail Onychomycosis
por: Chandra, Somodyuti, et al.
Publicado: (2019)

What’s New in Cryptococcus gattii: From Bench to Bedside and Beyond
por: Beardsley, Justin, et al.
Publicado: (2022)

Mixed infection by Cryptococcus neoformans and Cryptococcus gattii and coinfection with paracoccidioidomycosis in PLHIV
por: de Faria Ferreira, Marcela, et al.
Publicado: (2022)

Cytotoxic and Genotoxic Effects of Fluconazole on African Green Monkey Kidney (Vero) Cell Line
por: Correa, Regianne Maciel dos Santos, et al.
Publicado: (2018)

Lack of Cryptococcus gattii from Eucalyptus in Ahvaz
por: Salehei, Z, et al.
Publicado: (2015)

Unisexual Reproduction of Cryptococcus gattii
por: Phadke, Sujal S., et al.
Publicado: (2014)

Cryptococcus gattii in AIDS Patients, Southern California
por: Chaturvedi, Sudha, et al.
Publicado: (2005)

Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii
por: Farrer, Rhys A., et al.
Publicado: (2016)

Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii
por: Farrer, Rhys A., et al.
Publicado: (2015)

Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species
por: Schoffelen, Teske, et al.
Publicado: (2013)

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans
por: Bhattacharya, Somanon, et al.
Publicado: (2021)

Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii
por: Lam, Woei C., et al.
Publicado: (2019)

Polymorphism in Mitochondrial Group I Introns among Cryptococcus neoformans and Cryptococcus gattii Genotypes and Its Association with Drug Susceptibility
por: Gomes, Felipe E. E. S., et al.
Publicado: (2018)

Transcriptional Heterogeneity of Cryptococcus gattii VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways
por: Farrer, Rhys A., et al.
Publicado: (2018)

Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination With Fluconazole Against Candida albicans
por: Gong, Ying, et al.
Publicado: (2019)

Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
por: Chen, Xueqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_addj28vjtump1gjdl3atcbo07d